although recent reports suggest that a local imbalance in decidual cytokines, e.g. transforming growth factor β2, may
membrane blebbing and fragmentation into membrane-bound Programmed cell death by apoptosis occurs in both fetal vesicles known as apoptotic bodies (Wyllie et al., 1980) . The and maternal tissues during early pregnancy. To investigate cell remains and the apoptotic bodies are then phagocytosed a role for apoptosis at the maternal-fetal interface, we by neighbouring cells and macrophages with no accompanying have immunolocalized the bcl-2 protein in formalin-fixed inflammatory response (Thompson, 1994) . In contrast, necrosis decidual and placental tissue collected from women underaffects many cells within a tissue and is characterized by an going surgical termination of pregnancy (n ⍧ 22), from inflammatory reaction. Apoptosis is an essential feature of women undergoing a sporadic miscarriage (n ⍧ 16) and normal physiology in a variety of organs and is reported to from women with a history of recurrent pregnancy loss play an important role in fetal development (Thompson, 1994) . (more than three consecutive pregnancy losses; n ⍧ 22)
The regulation of apoptosis is complex and involves a undergoing a further miscarriage. In all three groups, bclfamily of related proteins which display either positive or 2 ⍣ cells were found in aggregates and dispersed in the negative regulatory effects. The proto-oncogene product bclstroma, and immunoreactivity was observed in glandular 2 is the prototype product of a family of genes associated epithelium. Double immunostaining revealed that a majorwith the inhibition of apoptosis (Wyllie, 1994) . Bcl-2 family ity of stromal bcl-2 ⍣ cells were CD56 ⍣ large granular members interact with each other through the formation of lymphocytes. A computerized image analysis revealed no homodimers and heterodimers, and one level of control is significant differences in percentage area of bcl-2 or CD56 ⍣ through the interaction of bcl-2-related apoptosis inhibitors immunostaining. Significantly more biopsies from the surand apoptosis promoters, e.g. bax (Oltavi et al., 1993) . gical termination group (4/10) had >20% positive immunoThere is increasing evidence that regulated apoptosis is staining for CD56 compared with 0% in the other two important during implantation and early pregnancy. Implantagroups combined (0/20; P < 0.05). Bcl-2 immunoreactivity tion and decidualization in the rat have been associated with was observed in the villi syncytiotrophoblast, and staining the progressive induction of apoptosis in the decidual cells intensity was consistently greater in the surgical terminalining the embryo, and decidualization in response to an tion group. The possible roles of bcl-2 at the maternalartificial stimulus has been associated with an increased expresfetal interface are discussed.
sion of bax and a decreased expression of bcl-2 (Parr et al., Key words: apoptosis/bcl-2/CD56/miscarriage /pregnancy 1987; Piacentini and Autori, 1994; Akcali et al., 1996) . In the human placenta, bcl-2 has been immunolocalized to the syncytiotrophoblast of the chorionic villi and appears to persist from the first trimester through to the third trimester of Introduction pregnancy (Sakuragi et al., 1994) . Indeed, Sakuragi et al. propose that this may be one mechanism by which trophoblast Approximately 15% of all recognized pregnancies miscarry during the first trimester. Recurrent miscarriage, defined as the mass is preserved during pregnancy. Bcl-2 immunopositive cells have also been identified in loss of three or more consecutive pregnancy losses, affects 2% of all pregnancies (Miller et al., 1980; Mills et al., 1988) .
non-pregnant endometrial stroma and in glandular epithelium (Koh et al., 1995; Tabibzadeh et al., 1995) . We have reported In women both with and without a history of recurrent miscarriage~60% of placental biopsies have an abnormal recently that both stromal and glandular bcl-2 concentrations are elevated during the late luteal phase but decreased when karyotype; in the remaining 40% of recurrent miscarriage cases investigations have failed to reveal a putative cause the luteal phase is extended with exogenous human chorionic gonadotrophin (Koh et al., 1995) . In the stroma, bcl-2 was (Stern et al., 1996) . In this subgroup, little is known about potential local intrauterine mechanisms of miscarriage, immunolocalized to CD56 ϩ large granular lymphocytes (LGL), 
Immunohistochemistry
which comprise the predominant leukocyte population in late secretory endometrium (Loke and King, 1995) . These cells
All biopsies were fixed in 10% neutral buffered formalin at 4°C overnight, rinsed and stored in 70% ethanol until routine wax also predominate in first trimester decidua but an association embedding. Sections (5 µm) were cut for the immunohistochemical with bcl-2 has not been reported previously.
localization of (i) bcl-2 protein, (i) CD56 ϩ large granular lymphocytes,
The possible regulatory role for apoptosis during implanta- recurrent miscarriage.
Both bcl-2 and CD56 epitopes were exposed by microwaving at high power in 0.01 M sodium citrate buffer (pH 6.0) for 3ϫ 5 min (bcl-2) or 4ϫ 5 min (CD56) and allowed to stand for a further 20 min. Following a further wash in TBS, non-specific endogenous peroxidase
Materials and methods
activity was blocked by treatment with 0.3% hydrogen peroxide in methanol for 30 min at room temperature. All tissue sections were Patients exposed to a non-immune block with normal horse serum for 20 Decidual and placental biopsies were collected from three groups of min at room temperature and then incubated with the appropriate patients: (i) women undergoing surgical termination of normally primary antibody. progressing pregnancies (n ϭ 22; 22 decidua and 12 chorionic villi samples), (ii) women undergoing evacuation of their uterus for an Immunolocalization of bcl-2 incipient sporadic miscarriage (n ϭ 16; 16 decidua and six chorionic Tissue sections were incubated with monoclonal mouse anti-human villi samples) and (iii) miscarrying women with a history of recurrent bcl-2 antibody at a dilution of 1 in 40 at 4°C overnight. Thereafter first trimester pregnancy loss (three or more consecutive miscarriages tissue sections were labelled with an avidin-biotin-peroxidase detecof unknown aetiology; n ϭ 22; 22 decidua and 12 chorionic villi tion system (Vector stain; Vector Laboratories, Peterborough, UK), samples). All recurrent miscarriage patients had been investigated which included the secondary biotinylated horse anti-mouse antibody. previously in terms of possible causes of miscarriage, and no reason Tissue sections were then incubated with diaminobenzidine (DAB) for their previous losses was found (Tulppala et al., 1993) . All solution (DAB kit; Vector Laboratories) for 10 min. Finally, the decidual biopsies were stained with a monoclonal antibody against sections were counterstained with haematoxylin, dehydrated, cleared cytokeratin to confirm the presence or absence of intermediate in xylene and mounted in Pertex Mounting Medium (Cellpath plc, trophoblast. On this basis, the decidua was classified as decidua Hemel Hempstead, Herts, UK). Negative controls were performed by basalis or decidua parietalis.
replacing the primary antibody with mouse immunoglobulin (Ig) at The diagnosis of normal and failing pregnancies was based on the same concentration as the primary antibody. transabdominal and/or transvaginal ultrasound. No woman undergoing a miscarriage had experienced any vaginal bleeding before the Immunolocalization of CD56 evacuation and all biopsies were collected by curettage. In the Tissue sections were incubated with monoclonal mouse anti-human recurrent miscarriage group, all pregnancies were followed regularly CD56 antibody at a dilution of 1 in 250 for 60 min at 37°C and at 1-2 week intervals by transvaginal ultrasound from 6-7 weeks labelled as above. gestation until a diagnosis of 'missed abortion' (fetal heart lost) or blighted ovum (only a gestational sac present) was diagnosed. Table I Double immunostaining for bcl-2 and CD56 illustrates that the biopsies were closely matched in terms of the gestational age at which the tissue was taken. With respect to the Mouse monoclonal antibody to bcl-2 was used, followed by biotwo groups of failing pregnancies, the proportions of blighted ovum tinylated horse anti-mouse antibody. Then the avidin-biotinperoxidase detection system was applied and developed with DAB and missed abortions diagnosed were comparable.
to generate a brown-coloured product. After washing, the sections In all biopsies examined from the three patient groups, were stained with mouse monoclonal antibody to CD56, followed by positive immunostaining for bcl-2 protein was observed in the biotinylated horse anti-mouse antibody, the same avidin-biotindecidual stroma and also the glandular epithelium ( Figure 1A ). peroxidase detection system, and developed with Vector VIP, which Stromal immunoreactivity was most marked in aggregates of generated a purple-coloured product. Negative controls were carried cells localized near glands and vessels, and some scattering of out where (i) anti-bcl-2 was replaced with normal mouse IgG followed bcl-2 ϩ cells was also noted ( Figure 1A) .
by anti-CD56; (ii) anti-bcl-2 was followed by normal mouse IgG in Double immunostaining revealed that a majority of stromal place of anti-CD56; and (iii) both primary antibodies were replaced bcl-2 ϩ cells were also positive for CD56. The co-localization by normal mouse IgG. As a control for the crossreactivity of antibodies, selected biopsy sections were subjected to double immunoof bcl-2 and CD56 was most prominent in lymphoid aggregates staining with the primary antibodies reversed.
close to vessels, and particularly around glands ( Figure 1B and C). In negative control semi-serial sections, where both anti-bcl-2 was followed by normal mouse IgG in place of anti-60 min at 37°C and labelled as above.
CD56, there was a complete absence of Vector VIP purple
Image analysis stain or DAB brown stain respectively (data not shown). When
To assess objectively decidual bcl-2 and CD56 immunostaining, 10 the primary antibodies were reversed for double immunobiopsies from each of the three groups were selected for image staining, similar proportions and distributions of Bcl-2 ϩ , analysis on the basis of good tissue morphology. The system employed CD56 ϩ cells were observed, indicating that the specificity of an Olympus BH2 microscope (ϫ20 objective) connected to a Macthe antibodies was not affected by the protocol.
Intosh Quadra 700 computer using Colour Vision software (ImproviIn 10 biopsies from each of the three groups, selected on sion, Coventry, UK). Quantitation was performed on the digitized the basis of good morphology, stromal immunostaining for image of randomly selected fields from which non-stromal elements bcl-2 and CD56 was quantitated using computer-assisted image (glandular epithelium) had been removed. Using colour discrimination software, the total area of positively staining cells (brown reaction analysis (see Materials and methods). Table II illustrates that product) was measured and expressed as a ratio to the area of all there were no significant differences between the groups in stromal nuclei (blue/purple haematoxylin). The running mean of the terms of the percentage area of nucleated cells immunostained ratio stabilized after measuring 12 fields (Lowrey et al., 1995) . for bcl-2 or CD56 independently. However, significantly more Consequently, the percentage of immunostained area biopsies from the surgical termination group exhibited a Ͼ20% to those decidual tissues from the surgical termination group Statistical analysis that were selected for image analysis, 50% were from primiparFisher's exact tests were performed on an Apple Macintosh computer ous patients who were given a pharmacological cervical using the statistical package 'Multistat' (Biosoft, Cambridge, UK).
ripening agent (Gemeprost, Farillon, Romford, Essex, UK; prostaglandin E1 analogue). In contrast, no cervical ripening agent was administered to the remaining multiparous patients.
Results
Comparison of the primiparous and multiparous patients in Decidua terms of percentage of nucleated cells immunostained for All decidual biopsies from women with a failing pregnancy CD56 (or bcl-2) did not reveal any correlation. It follows and a history of recurrent miscarriage (n ϭ 22) exhibited therefore that the result of four out of 10 surgical termination intermediate trophoblast after immunostaining with a monopatients with Ͼ20% CD56 immunostained nucleated cells was clonal anti-cytokeratin antibody and were therefore classified not a reflection of the termination method used. as decidua basalis. In the biopsies from women with a failing pregnancy but no previous miscarriages (n ϭ 16) and from Trophoblast women undergoing surgical termination of pregnancy (n ϭ
In first trimester chorionic villi from each group of patients, 22), intermediate trophoblast was observed in nine out of 16 positive immunostaining for bcl-2 was observed in only the (56.3%) and in 15 out of 22 (68.2%) patients respectively. A syncytiotrophoblast layer (Figure 2 ). In the surgical termination comparison of decidua basalis with decidua parietalis in terms group, the intensity of immunostaining was consistently greater of the distribution of bcl-2 and CD56 immunopositive cells than in the two groups of failing pregnancies, even when all did not reveal any differences (data not shown); thus all biopsies were included in the same immunostaining experiment decidual biopsies were included in the comparison of the (Figure 2A-C) . In negative control biopsies where the primary three groups (surgical termination, sporadic miscarriage and antibody was replaced with normal mouse Ig, the syncytiotrorecurrent miscarriage). An image analysis of the decidual biopsies (see below) confirmed this conclusion. phoblast was completely negative. Discussion be maintained during early pregnancy by one or more signals of placental origin. Indeed, endometrial CD56 ϩ LGL are Data presented here illustrate that the protein product of the reported to exhibit nuclear fragmentation, characteristic of proto-oncogene bcl-2 is present at the maternal-fetal interface apoptosis, a few days prior to the onset of menstruation (King in both healthy and incipiently failing first trimester pregnanet al., 1989) . The presence of bcl-2 on decidual CD56 ϩ LGL cies. Decidual and placental biopsies from failing pregnancies suggests that these cells have been selected for survival, thus were subdivided into those from women with and without a implying that these cells may play an important role in history of unexplained recurrent miscarriage. In all three groups implantation and early pregnancy. Recent studies in the human (surgical termination, sporadic miscarriage and recurrent missuggest that implantation may be regulated via an interaction carriage) we have shown that bcl-2 is localized to (i) CD56 ϩ between decidual LGL and extravillous trophoblast (Loke and LGL in decidual stroma, (ii) decidual glandular epithelium King, 1995) . It follows therefore that mechanisms to prevent and (iii) the syncytiotrophoblast of the chorionic villi. No apoptosis in these cells may be crucial for successful implantadifferences in bcl-2 localization or immunostaining intensity tion. This may be achieved through the secretion of cytokines were noted between the recurrent miscarriage and sporadic which may also have anti-apoptotic activity, e.g. granulocyte miscarriage groups. The surgical termination group differed macrophage colony-stimulating factor (Brach et al., 1992) . from the two groups of failing pregnancies in that the syncyData presented here confirm published data showing bcl-2 tiotrophoblast immunostaining intensity was consistently more protein in first trimester chorionic villi (Sakuragi et al., 1994) . intense, and significantly more biopsies from this group had
The greater intensity of syncytiotrophoblast immunostaining Ͼ20% immunostaining for CD56 as measured by image in the surgical termination group may reflect different local analysis. The percentage area of positive bcl-2 immunostaining environments where cytokines, e.g. tumour necrosis factor did not differ between any of the three groups.
Previously we have reported the co-localization of bcl-2 alpha (TNF-α), may affect bcl-2 expression. In this regard it protein to CD56 ϩ LGL in late secretory endometrium. Howis interesting to note that in the non-pregnant human uterus ever, during simulated early pregnancy by luteal rescue with the apoptosis of endometrial epithelial cells has been associated exogenous human chorionic gonadotrophin, stromal bcl-2 with increased endometrial TNFα release and decreased immunostaining was very limited (Koh et al., 1995) . This amounts of epithelial bcl-2 (Tabibzadeh et al., 1995) . Given contrasts with the present study where a high degree of positive the syncytium structure of the syncytiotrophoblast layer, the bcl-2 immunostaining was observed in decidual stroma during role of bcl-2 at this location may be unrelated to apoptosis. early pregnancy, i.e. when progesterone concentrations are However, the survival of the fetal syncytiotrophoblast in direct naturally high. The lack of bcl-2 in pseudo-pregnant endometcontact with maternal blood is crucial for successful pregnancy. rium when progesterone concentrations are maintained implies, Should syncytiotrophoblast bcl-2 function in a protective therefore, that bcl-2 expression on decidual CD56 ϩ LGL may (inhibition of apoptosis) capacity, lower amounts in the situation of a failing pregnancy may be expected. Indeed, the lack of a difference between the sporadic miscarriage and recurrent et al., 1995) . Ovarian abnormalities have termination) exhibited Ͼ20% immunostaining for CD56 (4/10) than in the two groups of failing pregnancies (0/20) (P Ͻ 0.05, Fisher's exact test).
also been observed in bax knockout mice (excess granulosa bcl-2 appears to be more intense in the surgical termination group than in the two groups of failing pregnancies. Scale bar ϭ 50 mm.
